Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;105:1071-1076
Published online before print February 11, 2002, doi: 10.1161/hc0902.104599
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
105/9/1071    most recent
hc0902.104599v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wachtell, K.
Right arrow Articles by Devereux, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wachtell, K.
Right arrow Articles by Devereux, R. B.
Related Collections
Right arrow Other myocardial biology
Right arrow Congestive
Right arrow Hypertrophy
Right arrow Clinical Studies

(Circulation. 2002;105:1071.)
© 2002 American Heart Association, Inc.


Clinical Investigation and Reports

Change in Diastolic Left Ventricular Filling After One Year of Antihypertensive Treatment

The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study

Kristian Wachtell, MD, PhD; Jonathan N. Bella, MD; Jens Rokkedal, MD; Vittorio Palmieri, MD; Vasilios Papademetriou, MD; Björn Dahlöf, MD, PhD; Tapio Aalto, MD; Eva Gerdts, MD, PhD; Richard B. Devereux, MD

From Copenhagen County University Hospital, Glostrup, Denmark (K.W., J.R.); Weill Medical College of Cornell University, New York, NY (K.W., J.N.B., V.P., R.B.D.); Veterans Affairs Medical Center, Washington, DC (V.P.); Sahlgrenska University Hospital-Östra, Göteborg, Sweden (B.D.); Helsinki University Central Hospital, Helsinki, Finland (T.A.); and Haukeland Hospital, Bergen, Norway (E.G.).

Correspondence to Dr Kristian Wachtell, Laboratory of Cardiology, Department of Medicine, Copenhagen County University Hospital, Glostrup, DK-2600 Glostrup, Denmark. E-mail kristian{at}wachtell.net

Background It is well established that hypertensive patients with left ventricular (LV) hypertrophy have impaired diastolic filling. However, the impact of antihypertensive treatment and LV mass reduction on LV diastolic filling remains unclear.

Methods and Results Echocardiograms were recorded in 728 hypertensive patients with ECG-verified LV hypertrophy (Cornell voltage-duration or Sokolow-Lyon) at baseline and after 1 year of blinded treatment with either losartan or atenolol-based regimen. Systolic and diastolic blood pressures (BP) were reduced on average 23/11 mm Hg; isovolumic relaxation time and E/A ratio became more normal, and LV inflow deceleration time prolonged (all P<0.001). Directionally opposite changes in isovolumic relaxation time (IVRT) and deceleration time indicate improvement in active LV relaxation and passive chamber stiffness during early diastole. Prevalences of normal LV filling increased, abnormal relaxation and pseudonormalization decreased, and restrictive filling pattern remained unchanged (P<0.05). Patients with reduction in LV mass had smaller left atrial diameter, shortened IVRT, increased E/A ratio, and prolonged LV inflow deceleration time (all P<0.001). Patients without LV mass reduction had no change in diastolic filling parameters (P=NS). IVRT shortening was independently associated with reduction in LV mass. Increase in E/A ratio was independently associated with reduction in diastolic BP, and increase in the deceleration time was independently associated with reduced end-systolic relative wall thickness.

Conclusions Antihypertensive therapy resulting in LV mass or relative wall thickness regression is associated with significant improvement of diastolic filling parameters related to active relaxation and passive chamber stiffness compared with patients without regression, independent of BP reduction; however, abnormalities of diastolic LV filling remain common.


Key Words: diastole • ventricles • hypertension • blood pressure




This article has been cited by other articles:


Home page
Eur J EchocardiogrHome page
P. Symeonides, S. Koulouris, E. Vratsista, K. Triantafyllou, G. Ioannidis, N. Thalassinos, and D. Katritsis
Both ramipril and telmisartan reverse indices of early diabetic cardiomyopathy: A comparative study
Eur J Echocardiogr, December 1, 2007; 8(6): 480 - 486.
[Abstract] [Full Text] [PDF]


Home page
J Am Board Fam MedHome page
S. Haney, D. Sur, and Z. Xu
Diastolic Heart Failure: A Review and Primary Care Perspective
J Am Board Fam Med, May 1, 2005; 18(3): 189 - 198.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
I N Alecrin, J M Aldrighi, M A Caldas, O C E Gebara, N H M Lopes, and J A F Ramires
Acute and chronic effects of oestradiol on left ventricular diastolic function in hypertensive postmenopausal women with left ventricular diastolic dysfunction
Heart, July 1, 2004; 90(7): 777 - 781.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. N. Bella, V. Palmieri, M. J. Roman, J. E. Liu, T. K. Welty, E. T. Lee, R. R. Fabsitz, B. V. Howard, and R. B. Devereux
Mitral Ratio of Peak Early to Late Diastolic Filling Velocity as a Predictor of Mortality in Middle-Aged and Elderly Adults: The Strong Heart Study
Circulation, April 23, 2002; 105(16): 1928 - 1933.
[Abstract] [Full Text] [PDF]